What are DNA's recent SEC filings?
8-K · OtherNov 5, 2026
Ginkgo Bioworks issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.
View full filing details →8-K · OtherOct 29, 2026
Ginkgo Bioworks announced it will host a presentation and Q&A session on November 5, 2026 to review its third quarter 2026 business performance. The announcement was made via a Regulation FD disclosure on Form 8-K.
View full filing details →Has DNA ever done a stock split?
Reverse Split40.0000-for-1.0000 (ratio: 0.025000)
Aug 20, 2024What is DNA's share float?
Public Float
$55.0M
Shares Outstanding
$63.7M
Free Float %
8639.0%
Get Real-Time DNA Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free